TrialInternational journal of clinical oncology2018

A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy.

Tsutomu Takahashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.